FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Adriana Scheliga

Research Profile

Disorders

Procedures

Concepts & Ideas

Chemicals & Drugs

Living Beings

Human Herpesvirus 4

Co-author Network

Publications

TOP 3
Renata Lyrio R Baptista; Irene Biasoli; Eloa Brabo; José Carlos Morais; Adriana Scheliga; Andrea Soares; Guilherme Loureiro Werneck; Nelson Spector
Psychometric properties of the multidimensional fatigue inventory in Brazilian Hodgkin's lymphoma survivors.
Andrea Soares; Guilherme Loureiro Werneck; Renata Lyrio Baptista; Irene Biasoli; Eloá Pereira Brabo; José Carlos Morais; Adriana Scheliga; Nelson Spector
Validation of the Brazilian Portuguese version of the Medical Outcomes Study-Social Support Survey in Hodgkin's lymphoma survivors.
Bertrand Coiffier; Michael Crump; Sven de Vos; Yusri A Elsayed; Christopher Enny; Dixie Esseltine; Xiaonan Hong; Jiri Mayer; Fritz Offner; Evgenii A Osmanov; Simon Rule; Adriana Scheliga; Ofer Shpilberg; Adriana Teixeira; Panteli Theocharous; Helgi van de Velde; Jan Walewski; Eugene Zhu; Pier Luigi Zinzani
Bortezomib plus rituximab versus rituximab alone in patients with relapsed, rituximab-naive or rituximab-sensitive, follicular lymphoma: a randomised phase 3 trial.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Adriana Scheliga (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Renata Lyrio R Baptista; Irene Biasoli; Eloa Brabo; José Carlos Morais; Adriana Scheliga; Andrea Soares; Guilherme Loureiro Werneck; Nelson Spector
Psychometric properties of the multidimensional fatigue inventory in Brazilian Hodgkin's lymphoma survivors.
Journal of pain and symptom management 2012;44(6):908-15.
2012: Andrea Soares; Guilherme Loureiro Werneck; Renata Lyrio Baptista; Irene Biasoli; Eloá Pereira Brabo; José Carlos Morais; Adriana Scheliga; Nelson Spector
Validation of the Brazilian Portuguese version of the Medical Outcomes Study-Social Support Survey in Hodgkin's lymphoma survivors.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2012;20(8):1895-900.
2011: Bertrand Coiffier; Michael Crump; Sven de Vos; Yusri A Elsayed; Christopher Enny; Dixie Esseltine; Xiaonan Hong; Jiri Mayer; Fritz Offner; Evgenii A Osmanov; Simon Rule; Adriana Scheliga; Ofer Shpilberg; Adriana Teixeira; Panteli Theocharous; Helgi van de Velde; Jan Walewski; Eugene Zhu; Pier Luigi Zinzani
Bortezomib plus rituximab versus rituximab alone in patients with relapsed, rituximab-naive or rituximab-sensitive, follicular lymphoma: a randomised phase 3 trial.
The lancet oncology 2011;12(8):773-84.
2010: Mário Henrique M Barros; Adriana Scheliga; Elena De Matteo; Carolina Minnicelli; Fernando A Soares; Ilana R Zalcberg; Rocio Hassan
Cell cycle characteristics and Epstein-Barr virus are differentially associated with aggressive and non-aggressive subsets of Hodgkin lymphoma in pediatric patients.
Leukemia & lymphoma 2010;51(8):1513-22.
2009: Denize Azambuja; Izidore S Lossos; Irene Biasoli; José Carlos Morais; Luciana Britto; Adriana Scheliga; Wolmar Pulcheri; Yasodha Natkunam; Nelson Spector
Human germinal center-associated lymphoma protein expression is associated with improved failure-free survival in Brazilian patients with classical Hodgkin lymphoma.
Leukemia & lymphoma 2009;50(11):1830-6.
2008: Vinicius Freitas Borlot; Irene Biasoli; Rony Schaffel; Denize Azambuja; Cristiane Milito; Ronir Raggio Luiz; Adriana Scheliga; Nelson Spector; José Carlos Morais
Evaluation of intra- and interobserver agreement and its clinical significance for scoring bcl-2 immunohistochemical expression in diffuse large B-cell lymphoma.
Pathology international 2008;58(9):596-600.
2008: Michael Pfreundschuh; Anthony Ho; Eva Cavallin-Stahl; Max Wolf; Ruth Pettengell; Ingrid Vasova; Andrew Belch; Jan Walewski; Pier Luigi Zinzani; Walter Mingrone; Stein Kvaloy; Ofer Shpilberg; Ulrich Jaeger; Mads Hansen; Claudia Corrado; Adriana Scheliga; Markus Loeffler; Evelyn Kuhnt
Prognostic significance of maximum tumour (bulk) diameter in young patients with good-prognosis diffuse large-B-cell lymphoma treated with CHOP-like chemotherapy with or without rituximab: an exploratory analysis of the MabThera International Trial Group (MInT) study.
The lancet oncology 2008;9(5):435-44.
2007: Luciana Britto; Nelson Spector; Adriana Scheliga
Predictive and discriminating three-risk-group prognostic scoring system for staging Hodgkin lymphomas.
Cancer 2007;110(1):228-9; author reply 229.
2007: Rony Schaffel; José Carlos Morais; Irene Biasoli; Joana Lima; Adriana Scheliga; Sérgio Romano; Cristiane Milito; Nelson Spector
PKC-beta II expression has prognostic impact in nodal diffuse large B-cell lymphoma.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2007;20(3):326-30.
2007: Andrea Soares; Irene Biasoli; Adriana Scheliga; Ronir Raggio Luiz; Mário Alberto Costa; Marcelo Land; Sérgio Romano; José Carlos Morais; Nelson Spector
Socioeconomic inequality and short-term outcome in Hodgkin's lymphoma.
International journal of cancer. Journal international du cancer 2007;120(4):875-9.
2006: Juliane Garcez Musacchio; M da G Carvalho; José Carlos Morais; Nathalie Henriques Silva; Adriana Scheliga; Sérgio Romano; Nelson Spector
Detection of free circulating Epstein-Barr virus DNA in plasma of patients with Hodgkin's disease.
São Paulo medical journal = Revista paulista de medicina 2006;124(3):154-7.
2006: Michael Pfreundschuh; Lorenz Trümper; Anders Osterborg; Ruth Pettengell; Marek Trneny; Kevin Imrie; David Ma; Devinder Gill; Jan Walewski; Pier Luigi Zinzani; Rolf Stahel; Stein Kvaloy; Ofer Shpilberg; Ulrich Jaeger; Mads Hansen; Tuula Lehtinen; Armando López-Guillermo; Claudia Corrado; Adriana Scheliga; Noël Milpied; Myriam Mendila; Michelle Rashford; Evelyn Kuhnt; Markus Loeffler
CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group.
The lancet oncology 2006;7(5):379-91.
2005: Irene Biasoli; José Carlos Morais; Adriana Scheliga; Cristiane Milito; Sérgio Romano; M Land; Wolmar Pulcheri; Nelson Spector
CD10 and Bcl-2 expression combined with the International Prognostic Index can identify subgroups of patients with diffuse large-cell lymphoma with very good or very poor prognoses.
Histopathology 2005;46(3):328-33.